Hilleman and Bharat Biotech launch oral cholera vaccine in India - BioProcess International

Hilleman Laboratories' partner Bharat Biotech launched Hillchol oral cholera vaccine, using a single, genetically engineered Hikojima strain. Approved in India, Bharat Biotech aims for WHO prequalification for global distribution. The vaccine, developed through collaboration, addresses global cholera vaccine shortages.